Table 1.
Active | Placebo | ||
---|---|---|---|
Number of dermatomes involved at 24 h | |||
Pin Prick |
1.5 (0–3) |
0 (0–0) |
P=0.039 |
Heat/Cold |
2.0 (0–3) |
0 (0–0) |
P=0.034 |
Upper and lower dermatomal involvement (Pin Prick) |
|
||
1h |
T10 to T12 |
T10 to T12 |
|
4h |
T10 to T11 |
T10 to T12 |
|
8h |
T11 to T12 |
T11 to T12 |
|
12h |
T10 to T12 |
None |
|
24h |
T10 to T11 |
None |
|
Upper and lower dermatomal involvement (cold test) | |||
1h |
T10 to T12 |
T10 to T12 |
|
4h |
T10 to T12 |
T10 to T12 |
|
8h |
T11 to T12 |
T10 to T12 |
|
12h |
T11 to T12 |
None |
|
24h | T10 to T11 | None |
Median and (minimum-maximum).
Sensory spread after TAP block and infusion via TAP catheters. Active indicates infusion with ropivacaine and placebo with saline in the TAP catheters. The hours indicate time from TAP block performance.